Biotechnology company specializing in clinical research to develop potential clinical treatment and wellness products to address mental illness conditions and weight management conditions NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) announced having received approval from Health Canada for its functional mushroom product ‘Mindful Blend.’
The Mindful Blend uses 100% plant-based extracts which are formulated to support memory and cognitive functions, fight stress, reduce inflammation and support the immune system.
Health Canada approved the Mindful Blend under Product License NPN 80111611. Natural Health Products (NHP) are required to undergo a vigorous review by Health Canada’s Natural Health Product Directorate (NHPD) to ensure the safety and efficacy of the product.
NeonMind’s consumer products do not contain restricted or psychoactive substances, its consumer products unit includes four dietary supplements.
“The approval from Health Canada allows us to market the proven benefits of our functional mushroom ingredients, differentiating the NeonMind brand as we introduce additional products across the U.S. and Canada. Our consumer products division allows NeonMind to further our reach into the massive functional food market. We continue to meet our strategic operational timelines while also supporting our research and development initiatives,” said the company’s CEO, Rob Tessarolo.
